PBD Biotech has secured a £2.3m investment to take Actiphage through to validation by the World Organisation for Animal Health (OIE). Full validation will enable international adoption of this novel, patented, diagnostic for mycobacterial diseases, which include human tuberculosis and...
PBD Biotech has secured a £2.3m investment to take Actiphage through to validation by the World Organisation for Animal Health...